Advertisement

Pharmacy World and Science

, Volume 27, Issue 2, pp 73–75 | Cite as

Applying health technology assessment to pharmaceutical care: pitfalls and future directions

  • Steven SimoensEmail author
  • Gert Laekeman
Article

Abstract

It has been argued in previous issues of this journal that health technology assessment can be used as a tool to assess the efficiency of pharmaceutical care by linking its impact on clinical and humanistic outcomes to the resources required to achieve these outcomes. Additionally, as policy-makers appreciate the need to evaluate projects on the basis of their costs and benefits, the application of health technology assessment to pharmaceutical care may serve as a way of communicating with policy-makers and informing policy on pharmaceutical care.

This article elaborates on this idea by arguing that policy-makers will be more likely to appreciate the value of pharmaceutical care if researchers pay more attention to some methodological principles underlying health technology assessment in the context of pharmaceutical care, and if they take into account the decision-making context facing policy-makers. In order to raise the methodological quality of studies, researchers need to take care to define better the pharmaceutical care intervention; to evaluate the costs of the intervention and its impact on the utilization of other health services; and to aggregate the various clinical and humanistic outcome measures that are commonly used in this type of research. In order to increase the usefulness of study findings to policy-makers, researchers need to identify the multiple objectives that policy-makers pursue, and show how study findings will aid policy-makers in attaining these objectives.

Keywords

Health technology assessment Pharmaceutical care Methodology Decision-making 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Postma, MJ. 2003Pharmacoeconomic researchPharm World Sci252456CrossRefPubMedGoogle Scholar
  2. Traulsen, JM, Klinke, BO. 2004Using health technology assessment to put pharmaceutical care on the political agendaPharm World Sci26613CrossRefPubMedGoogle Scholar
  3. Plumridge, RJ, Wojnar-Horton, RE. 1998A review of the pharmacoeconomics of pharmaceutical carePharmacoeconomics1417589PubMedGoogle Scholar
  4. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes (Cochrane Review). The Cochrane Library, Issue 4, 2003. Chichester: John Wiley and Sons.Google Scholar
  5. Singhal, PK, Raisch, DW, Gupchup, GV. 1999The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future researchAnn Pharmacother33133655CrossRefPubMedGoogle Scholar
  6. Drummond, M. 2004Economic evaluation in health care: is it really useful or are we just kidding ourselves?Austr Econ Rev37311CrossRefGoogle Scholar
  7. Mil, JWF. 1999Pharmaceutical care, the future of pharmacy. Theory, research and practice. GroningenDrukkerij De VolhardingThe Netherlands19Google Scholar
  8. Odedina, FT, Hepler, CD, Segal, R, Miller, D. 1997The Pharmacists’ Implementation of Pharmaceutical Care (PIPC) modelPharm Res1413544CrossRefPubMedGoogle Scholar
  9. Odedina, FT, Segal, R. 1996Behavioral pharmaceutical care scale for measuring pharmacists’ activitiesAm J Health Syst Pharm5385565PubMedGoogle Scholar
  10. Ellwein, LB, Drummond, M. 1996Economic analysis alongside clinical trials. Bias in the assessment of economic outcomesInt J Technol Assess Health Care126917PubMedGoogle Scholar
  11. Mason, J. 1997The generalisability of pharmacoeconomic studiesPharmacoecon1150314Google Scholar
  12. Drummond, M, Jönsson, B. 2003Moving beyond the drug budget silo mentality in EuropeValue in Health6S74S7CrossRefPubMedGoogle Scholar
  13. Drummond, M, Brown, R, Fendrick, AM, Fullerton, P, Neumann, P, Taylor, R, Barbieri, M. 2003Use of pharmacoeconomics information – report of force the ISPOR task force on use of pharmacoeconomic/health economic information in health-care decision-makingValue Health640716CrossRefPubMedGoogle Scholar
  14. Piaget, J, Inhelder, B. 1969The psychology of the childBasic BooksNew YorkGoogle Scholar
  15. Hoffmann, C, Schulenburg, JM. 2000The influence of economic evaluation studies on decision-makingA European survey. Health Pol5217992Google Scholar
  16. Ross, J. 1995The use of economic evaluation in health care: Australian decision-makers’ perceptionsHealth Pol3110310CrossRefGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Faculty of Pharmaceutical SciencesKatholieke Universiteit LeuvenLeuvenBelgium

Personalised recommendations